Blood Transfusion Diagnostics Market Report 2026

Blood Transfusion Diagnostics Market Overview

• Blood Transfusion Diagnostics market size has reached to $4.96 billion in 2025 • Expected to grow to $6.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Emerging Importance Of Blood Transfusion Diagnostics In The Surge Of Surgical Procedures • Market Trend: A Revolutionary Platform for Enhanced Blood Transfusion Diagnostics • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Blood Transfusion Diagnostics Market?

Blood transfusion diagnostics are used to conduct tests before the transfusion of blood from donor-recipient such as blood grouping disease screening. The main types of blood transfusion diagnostics are instruments and kits, reagents, and others. The blood transfusion diagnostic kits are used to collect and transfuse blood. The technologies involved in blood transfusion diagnostics are western blot, ELISA, nucleic acid amplification, fluorescence assay, and rapid tests that are used for various applications such as blood grouping and disease screening. The end-users involved are hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies.

What Is The Blood Transfusion Diagnostics Market Growth Forecast?

The blood transfusion diagnostics market size is expected to see strong growth in the next few years. It will grow to $6.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to development of high-throughput automated blood screening systems, increasing demand for nucleic acid amplification and rapid tests, rising investment in blood banks and diagnostic laboratories, adoption of digital and AI-enabled diagnostic solutions, expansion of plasma fractionation and research activities. Major trends in the forecast period include rising demand for rapid and accurate blood typing, increasing adoption of automated blood processing systems, expansion of disease screening capabilities, growth in plasma fractionation and diagnostic laboratories, enhanced focus on standardization and quality control.

Global Blood Transfusion Diagnostics Market Segmentation

1) By Type: Instruments And Kits, Reagents, Other Types 2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test 3) By Application: Blood Grouping, Disease Screening 4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies Subsegments: 1) By Instruments And Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems 2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes And Other Reagents 3) By Other Types: Software Solutions, Consumables, Training And Support Services

What Are The Drivers Of The Blood Transfusion Diagnostics Market?

The rising number of surgical procedures is expected to propel the growth of the blood transfusion diagnostics market going forward. Surgical procedures refer to medical operations performed to treat injuries, diseases, or disorders through manual or instrumental techniques. As the global volume of surgeries increases, so does the need for safe and compatible blood transfusions to replace blood lost during these procedures. Blood transfusion diagnostics play a critical role in screening and matching donor blood to prevent transfusion-related infections and complications, ensuring patient safety and improving clinical outcomes. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the increasing number of surgical procedures is driving the growth of the blood transfusion diagnostics industry. The growing prevalence of blood-related diseases is expected to propel the growth of the blood transfusion diagnostics market going forward. Blood-related diseases encompass a wide range of disorders that affect the composition, function, or production of blood and its components, including anemias, leukemia, and clotting disorders. Blood transfusion diagnostics aid in the early detection and safe management of blood-related diseases, ensuring compatible blood products and reducing the risk of complications for patients. For instance, in January 2023, according to the American Cancer Society Inc., a US-based professional organization, there were around 59,610 new cases of leukemia (all types) and 23,710 deaths from leukemia (all types). There are around 20,380 new cases of acute myeloid leukemia (AML). Therefore, the growing prevalence of blood-related diseases is driving the growth of the blood transfusion diagnostics industry.

Key Players In The Global Blood Transfusion Diagnostics Market

Major companies operating in the blood transfusion diagnostics market are Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Grifols SA, Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical, HLL Lifecare Limited.

Global Blood Transfusion Diagnostics Market Trends and Insights

Major companies in the blood transfusion diagnostics market are developing advanced technology, such as innovations in transfusion technology, to enhance the accuracy of blood typing, improve patient safety, reduce the risk of transfusion-transmitted infections, and streamline the overall transfusion process. Innovations in transfusion technology refer to advancements and improvements in the methods, devices, and processes used in blood transfusion. For instance, in June 2024, Innobiochips Co. Ltd., a France-based biotechnology company, launched Omnys, a major innovation in transfusion, grouping, and blood testing. It is a cutting-edge diagnostic platform designed to provide rapid and accurate blood typing, compatibility testing, and pathogen detection. This innovative technology leverages advanced biomarker identification and automation to streamline the transfusion process, ensuring that blood products are safely matched to patients.

Regional Outlook

North America was the largest region in the blood transfusion diagnostics market in 2025. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Blood Transfusion Diagnostics Market?

The blood transfusion diagnostics market consists of revenues earned by entities by providing installation and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood transfusion diagnostics market also includes sales of blood transfusion diagnostics devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.